CA Plan to Legalize Psychedelics is Dangerous for Mental Health & Patient Lives
California policy makers are being asked to support the resurgence of a past failed and dangerous psychiatric-psychedelic drug practice that went from a research lab…
California policy makers are being asked to support the resurgence of a past failed and dangerous psychiatric-psychedelic drug practice that went from a research lab…
Rev. Shaw from the group’s Racism Task Force also cautions African Americans against offers to treat racial trauma with psychedelics, citing history of racist psychiatric…
Current research into psychedelic drugs in the treatment of mental disorders is heading in a dangerous “Brave New World” direction. With a history of psychiatric-intelligence…
Low doses of psychedelic drugs, including lysergic acid diethylamide (LSD), ketamine, and psilocybin, may reduce clinical symptoms in patients with depression, anxiety, obsession-compulsive disorders (OCDs), and chronic pain, without inducing depersonalization or hallucinations, according to a new Perspectives article published online August 18 in Nature Reviews Neuroscience.
Bobby is seven years old, but this is not the first time he has been subjected to electroshock. It’s his third time. In all, over the next year, Bobby will experience eight electroshock sessions. Placed on the examining table, he is held down by two male attendants while the physician places a solution on his temples. Bobby struggles with the two men holding him down, but his efforts are useless. He cries out and tries to pull away. One of the attendants tries to force a thick wedge of rubber into his mouth. He turns his head sharply away and cries out, “Let me go, please. I don’t want to be here. Please, let me go.”